Shanghai Aohua Photoelectricity Endoscope Co. Ltd. A
Shanghai Aohua Photoelectricity Endoscope Co., Ltd. engages in the research and development, manufacture, and sale of electronic endoscope equipment and endoscopic diagnosis and treatment consumables in China and internationally. It offers electronic digestive endoscopes, otolaryngoscopes, bronchoscopes, and endoscopic diagnostic and treatment consumables for use in respiratory medicine, general … Read more
Shanghai Aohua Photoelectricity Endoscope Co. Ltd. A (688212) - Total Liabilities
Latest total liabilities as of June 2025: CN¥580.99 Million CNY
Based on the latest financial reports, Shanghai Aohua Photoelectricity Endoscope Co. Ltd. A (688212) has total liabilities worth CN¥580.99 Million CNY as of June 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Shanghai Aohua Photoelectricity Endoscope Co. Ltd. A - Total Liabilities Trend (2019–2024)
This chart illustrates how Shanghai Aohua Photoelectricity Endoscope Co. Ltd. A's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Shanghai Aohua Photoelectricity Endoscope Co. Ltd. A Competitors by Total Liabilities
The table below lists competitors of Shanghai Aohua Photoelectricity Endoscope Co. Ltd. A ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Chengdu KSW Technologies Co. Ltd. A
SHG:688283
|
China | CN¥183.19 Million |
|
Fujian Nanping Sun Cable Co Ltd
SHE:002300
|
China | CN¥4.44 Billion |
|
Beijing New Space Technology Co Ltd
SHG:605178
|
China | CN¥422.91 Million |
|
Kunshan Huguang Auto Harness Co Ltd
SHG:605333
|
China | CN¥5.42 Billion |
|
Cromwell Property Group
PINK:CMWCF
|
USA | $816.50 Million |
|
Hammond Power Solutions Inc
PINK:HMDPF
|
USA | $239.26 Million |
|
Sage Therapeutics Inc
NASDAQ:SAGE
|
USA | $54.19 Million |
Liability Composition Analysis (2019–2024)
This chart breaks down Shanghai Aohua Photoelectricity Endoscope Co. Ltd. A's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 2.55 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.46 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.31 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Shanghai Aohua Photoelectricity Endoscope Co. Ltd. A's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Shanghai Aohua Photoelectricity Endoscope Co. Ltd. A (2019–2024)
The table below shows the annual total liabilities of Shanghai Aohua Photoelectricity Endoscope Co. Ltd. A from 2019 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | CN¥368.20 Million | +84.20% |
| 2023-12-31 | CN¥199.88 Million | +12.00% |
| 2022-12-31 | CN¥178.46 Million | +97.51% |
| 2021-12-31 | CN¥90.36 Million | +4.11% |
| 2020-12-31 | CN¥86.79 Million | +10.72% |
| 2019-12-31 | CN¥78.39 Million | -- |